This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Sep;122(9):1737-9.

doi: 10.1016/j.ophtha.2015.06.022.

MIGS and the FDA: What's in a Name?

Iqbal Ike K Ahmed¹

Affiliations

PMID: 26299720
DOI: 10.1016/j.ophtha.2015.06.022

Editorial

MIGS and the FDA: What's in a Name?

Iqbal Ike K Ahmed. Ophthalmology. 2015 Sep.

. 2015 Sep;122(9):1737-9.

doi: 10.1016/j.ophtha.2015.06.022.

Author

Iqbal Ike K Ahmed¹

Affiliation

¹ Toronto, Canada.

PMID: 26299720
DOI: 10.1016/j.ophtha.2015.06.022

No abstract available

PubMed Disclaimer

Comment on

Special Commentary: Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014.
Caprioli J, Kim JH, Friedman DS, Kiang T, Moster MR, Parrish RK 2nd, Rorer EM, Samuelson T, Tarver ME, Singh K, Eydelman MB. Caprioli J, et al. Ophthalmology. 2015 Sep;122(9):1795-801. doi: 10.1016/j.ophtha.2015.02.029. Epub 2015 Apr 14. Ophthalmology. 2015. PMID: 25881513 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information